No Cover Image

Journal article 667 views 197 downloads

New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice

Marc Evans, Angharad R. Morgan, Martin B. Whyte, Wasim Hanif, Steve Bain Orcid Logo, Philip A. Kalra, Sarah Davies, Umesh Dashora, Zaheer Yousef, Dipesh C. Patel, W. David Strain

Drugs, Volume: 82, Issue: 2, Pages: 97 - 108

Swansea University Author: Steve Bain Orcid Logo

Check full text

DOI (Published version): 10.1007/s40265-021-01655-2

Published in: Drugs
ISSN: 0012-6667 1179-1950
Published: Springer Science and Business Media LLC 2022
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa58766
first_indexed 2021-11-24T12:30:41Z
last_indexed 2022-03-16T04:30:33Z
id cronfa58766
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2022-03-15T15:55:13.1583481</datestamp><bib-version>v2</bib-version><id>58766</id><entry>2021-11-24</entry><title>New Therapeutic Horizons in Chronic&#xA0;Kidney&#xA0;Disease: The Role of SGLT2 Inhibitors in Clinical Practice</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2021-11-24</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Drugs</journal><volume>82</volume><journalNumber>2</journalNumber><paginationStart>97</paginationStart><paginationEnd>108</paginationEnd><publisher>Springer Science and Business Media LLC</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0012-6667</issnPrint><issnElectronic>1179-1950</issnElectronic><keywords/><publishedDay>1</publishedDay><publishedMonth>2</publishedMonth><publishedYear>2022</publishedYear><publishedDate>2022-02-01</publishedDate><doi>10.1007/s40265-021-01655-2</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm>Other</apcterm><funders>AstraZeneca UK Ltd</funders><lastEdited>2022-03-15T15:55:13.1583481</lastEdited><Created>2021-11-24T12:27:06.7217285</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Marc</firstname><surname>Evans</surname><order>1</order></author><author><firstname>Angharad R.</firstname><surname>Morgan</surname><order>2</order></author><author><firstname>Martin B.</firstname><surname>Whyte</surname><order>3</order></author><author><firstname>Wasim</firstname><surname>Hanif</surname><order>4</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>5</order></author><author><firstname>Philip A.</firstname><surname>Kalra</surname><order>6</order></author><author><firstname>Sarah</firstname><surname>Davies</surname><order>7</order></author><author><firstname>Umesh</firstname><surname>Dashora</surname><order>8</order></author><author><firstname>Zaheer</firstname><surname>Yousef</surname><order>9</order></author><author><firstname>Dipesh C.</firstname><surname>Patel</surname><order>10</order></author><author><firstname>W. David</firstname><surname>Strain</surname><order>11</order></author></authors><documents><document><filename>58766__21664__db3d27f3983244ef8597b3ea57951102.pdf</filename><originalFilename>Evans2021.pdf</originalFilename><uploaded>2021-11-24T12:30:09.1831095</uploaded><type>Output</type><contentLength>366978</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2022-12-21T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807>
spelling 2022-03-15T15:55:13.1583481 v2 58766 2021-11-24 New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2021-11-24 MEDS Journal Article Drugs 82 2 97 108 Springer Science and Business Media LLC 0012-6667 1179-1950 1 2 2022 2022-02-01 10.1007/s40265-021-01655-2 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University Other AstraZeneca UK Ltd 2022-03-15T15:55:13.1583481 2021-11-24T12:27:06.7217285 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Marc Evans 1 Angharad R. Morgan 2 Martin B. Whyte 3 Wasim Hanif 4 Steve Bain 0000-0001-8519-4964 5 Philip A. Kalra 6 Sarah Davies 7 Umesh Dashora 8 Zaheer Yousef 9 Dipesh C. Patel 10 W. David Strain 11 58766__21664__db3d27f3983244ef8597b3ea57951102.pdf Evans2021.pdf 2021-11-24T12:30:09.1831095 Output 366978 application/pdf Accepted Manuscript true 2022-12-21T00:00:00.0000000 true eng
title New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice
spellingShingle New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice
Steve Bain
title_short New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice
title_full New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice
title_fullStr New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice
title_full_unstemmed New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice
title_sort New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain
author Steve Bain
author2 Marc Evans
Angharad R. Morgan
Martin B. Whyte
Wasim Hanif
Steve Bain
Philip A. Kalra
Sarah Davies
Umesh Dashora
Zaheer Yousef
Dipesh C. Patel
W. David Strain
format Journal article
container_title Drugs
container_volume 82
container_issue 2
container_start_page 97
publishDate 2022
institution Swansea University
issn 0012-6667
1179-1950
doi_str_mv 10.1007/s40265-021-01655-2
publisher Springer Science and Business Media LLC
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2022-02-01T20:07:49Z
_version_ 1821346805619621888
score 11.04748

Similar Items